1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, June 2013 (p40)

Drug Discovery and Development Analysis & Statistics, June 2013 (p40)

24/7 Customer Support

Talk to Clare

+44 20 8144 3147

1171-1200 of about 1 600 reports

Purchase Reports From Reputable Market Research Publishers

Triple Analysis: Lung Cancer, Melanoma and Apoptosis

Triple Analysis: Lung Cancer, Melanoma and Apoptosis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lymphoma, Melanoma and Apoptosis

Triple Analysis: Lymphoma, Melanoma and Apoptosis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical
Triple Analysis: Melanoma, Apoptosis and Angiogenesis

Triple Analysis: Melanoma, Apoptosis and Angiogenesis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Breast Cancer, Lung Cancer and Melanoma

Triple Analysis: Breast Cancer, Lung Cancer and Melanoma

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lymphoma and Melanoma

Triple Analysis: Breast Cancer, Lymphoma and Melanoma

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer

Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Melanoma and Apoptosis

Triple Analysis: Breast Cancer, Melanoma and Apoptosis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Melanoma and Angiogenesis

Triple Analysis: Breast Cancer, Melanoma and Angiogenesis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Melanoma and Cancer Vaccines

Triple Analysis: Breast Cancer, Melanoma and Cancer Vaccines

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Pathology, Drug Discovery and Development
Triple Analysis: Breast Cancer, Melanoma and Antibodies

Triple Analysis: Breast Cancer, Melanoma and Antibodies

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Colorectal Cancer, Melanoma and Pancreatic Cancer

Triple Analysis: Colorectal Cancer, Melanoma and Pancreatic Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Melanoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical
Triple Analysis: Leukemia, Melanoma and Pancreatic Cancer

Triple Analysis: Leukemia, Melanoma and Pancreatic Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia, Melanoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria in a ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical
Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer

Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Melanoma and Prostate Cancer

Triple Analysis: Colorectal Cancer, Melanoma and Prostate Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Leukemia, Melanoma and Prostate Cancer

Triple Analysis: Leukemia, Melanoma and Prostate Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Lung Cancer, Melanoma and Prostate Cancer

Triple Analysis: Lung Cancer, Melanoma and Prostate Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lymphoma, Melanoma and Prostate Cancer

Triple Analysis: Lymphoma, Melanoma and Prostate Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lymphoma, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Melanoma, Pancreatic Cancer and Prostate Cancer

Triple Analysis: Melanoma, Pancreatic Cancer and Prostate Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Melanoma, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Melanoma, Prostate Cancer and Apoptosis

Triple Analysis: Melanoma, Prostate Cancer and Apoptosis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Melanoma, Prostate Cancer and Angiogenesis

Triple Analysis: Melanoma, Prostate Cancer and Angiogenesis

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines

Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Melanoma, Prostate Cancer and Protein Kinase Inhibitors

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Pathology, Drug Discovery and Development
Triple Analysis: Melanoma, Prostate Cancer and Antibodies

Triple Analysis: Melanoma, Prostate Cancer and Antibodies

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma

Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Leukemia and Melanoma

Triple Analysis: Breast Cancer, Leukemia and Melanoma

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Breast Cancer, Melanoma and Peptides

Triple Analysis: Breast Cancer, Melanoma and Peptides

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Melanoma and Peptides

Triple Analysis: Colorectal Cancer, Melanoma and Peptides

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical
Triple Analysis: Leukemia, Melanoma and Peptides

Triple Analysis: Leukemia, Melanoma and Peptides

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
Triple Analysis: Lung Cancer, Melanoma and Pancreatic Cancer

Triple Analysis: Lung Cancer, Melanoma and Pancreatic Cancer

  • € 3 450
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer, Melanoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.